手术室护理干预对急性脑出血预后和并发症的影响

Effect of Nursing Intervention in Operating Room on Prognosis and Complications for Acute Cerebral Hemorrhage

目的探讨手术室护理干预对急性脑出血预后和并发症的影响。方法选择于2017年10月—2018年10月间院内收治的112例急性脑出血患者作为观察对象,采用随机数字表法将其分为观察组和对照组,各56例,对照组给予院内常规护理措施,观察组给予手术室护理干预措施,比较两组患者预后及并发症发生情况。结果观察组总有效率91.07%,显著优于对照组的62.50%,两组比较差异有统计学意义(χ^2=6.731,P=0.023)。两组治疗后Barthel指数评分及Fegl-Mevyer均显著优于治疗前,观察组治疗后Barthel指数评分及Fegl-Mevyer均显著优于对照组,比较差异有统计学意义(P<0.05)。观察组病死率及并发症发生情况均显著低于对照组,比较差异有统计学意义(χ^2=7.162,P=0.012)。结论两种护理方式均能在一定程度上提高患者的预后,减少并发症的发生,但比较而言,手术室护理干预措施能更进一步降低患者死亡率,提高预后,值得在临床中进一步推广应用。

Objective To investigate the effects of surgical intervention on the prognosis and complications of acute cerebral hemorrhage.Methods 112 patients with acute intracerebral hemorrhage admitted in the hospital from October 2017 to October 2018 were selected as the objects.They were divided into 56 cases in each group.The control group was given routine nursing measures while the observation group was gave nursing interventions on the basis of the control group.The prognosis and complications of the two groups were compared.Results The total effective rate of the observation group was 91.07% higher than 62.50% of the control group.The difference between the two groups was statistically significant(χ^2=6.731,P=0.023).After treatment,the Bartel index score and Fegl-Mevyer were significantly better than before treatment.After treatment,the Barthel index score and the Fegl-Mevyer of the observation group were significantly better than the control group,and the difference was statistically significant (P<0.05).The mortality rate and complications in the observation group were significantly lower than which of the control group,and the difference was statistically significant (χ^2=7.162,P=0.012).Conclusion Both nursing methods can improve the prognosis of patients in some extent,reduce the occurrence of complications,but in comparison,operating room nursing intervention can further reduce the mortality of patients,improve the prognosis,it is worth to be further promotion in clinical application.